Evaluation of BNT162b2 vaccine effectiveness in Malaysia: test negative case-control study
Audrey Huili Lim(Ministry of Health), Sheamini Sivasampu(Ministry of Health), Zhi Shan Sujata Tan(Ministry of Health), Ismuni Bohari(Ministry of Health), Ishvinder Singh Parmar(Ministry of Health), Norazida Ab Rahman(Hospital Kuala Lumpur), Kalaiarasu M. Peariasamy(Ministry of Health), Rahmah Rashid(Ministry of Health), Siti Nadiah Dahlan(Ministry of Health), Su Miin Ong(National Institutes of Health), Jubaida Paraja(Ministry of Health)
Cited by 6
Related Papers
Efficacy of telemedicine for the management of cardiovascular disease: a systematic review and meta-analysis
|The Lancet Digital Health|2022|178
Clinical characteristics and risk factors for severe COVID-19 infections in Malaysia: A nationwide observational study
|The Lancet Regional Health - Western Pacific|2020|132
Efficacy of Ivermectin Treatment on Disease Progression Among Adults With Mild to Moderate COVID-19 and Comorbidities
|JAMA Internal Medicine|2022|105
Influence of Population Density for COVID-19 Spread in Malaysia: An Ecological Study
|International Journal of Environmental Research and Public Health|2021|85
Waning COVID-19 Vaccine Effectiveness for BNT162b2 and CoronaVac in Malaysia: An Observational Study
|International Journal of Infectious Diseases|2022|79